0000899243-16-011555.txt : 20160112
0000899243-16-011555.hdr.sgml : 20160112
20160112160711
ACCESSION NUMBER: 0000899243-16-011555
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160108
FILED AS OF DATE: 20160112
DATE AS OF CHANGE: 20160112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashburn Theodore
CENTRAL INDEX KEY: 0001627978
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 161338875
MAIL ADDRESS:
STREET 1: 1688 WASHINGTON STREET #1
CITY: BOSTON
STATE: MA
ZIP: 02118
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-01-08
0
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001627978
Ashburn Theodore
C/O DICERNA PHARMACEUTICALS, INC.
87 CAMBRIDGEPARK DRIVE
CAMBRIDGE
MA
02140
0
1
0
0
See Remarks
Employee Stock Option (Right to Buy)
9.09
2016-01-08
4
A
0
75000
0.00
D
2026-01-08
Common Stock
75000
75000
D
The option vests in 48 monthly installments over the four-year period with a vesting start date of January 8, 2016, subject in each case to the reporting person's continued employment with the issuer through the applicable vesting date.
Senior Vice President, Product Strategy and Operations
/s/ Michael Todisco, attorney-in-fact
2016-01-12